Medirom Healthcare TechnologMRM

13F holders, Q3 2024 (September 30)
3holders +1
1new positions
0sold out
$3.01avg. 13F price*

At the end of Q3 2024, 3 institutions reported holding Medirom Healthcare Technolog (MRM) in their 13F filings, up 1 from Q2 2024. 1 opened new positions and 0 sold out. The largest holders were UBS Group AG ($54K), Virtu Financial LLC ($33K) and Bank of America Corp. ($75).

Company
Medirom Healthcare Technolog
CUSIP
58510H103
Latest filing quarter
Q2 2026

History

Number of 13F holders

02468 Q1 2024: 1Q1 2024Q2 2024: 2Q2 2024Q3 2024: 3Q3 2024Q4 2024: 5Q4 2024Q1 2025: 3Q1 2025Q2 2025: 6Q2 2025Q3 2025: 4Q3 2025Q4 2025: 3Q4 2025Q1 2026: 5Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions1$33K
Exits0$0

All 13F filers, Q2 2024 → Q3 2024: 28,949 shares bought, net +28,949 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 3 holders

UBS Group AG 0.00% Add +60023.3% 18,037 $54K
Virtu Financial LLC 0.00% New 10,942 $33K
Bank of America Corp. 0.00% No change 25 $75

"% of holder's portfolio" is MRM's weight in each manager's 13F, not the share of Medirom Healthcare Technolog the manager owns.